Amarin Corp Plcuk (AMRN) Construction in Progress (2011 - 2016)
Amarin Corp Plc\Uk (AMRN) posted quarterly Construction in Progress of $12000.0 for Q4 2016, down 83.33% quarter-over-quarter from $72000.0 in Q4 2012.
Amarin Corp Plcuk (AMRN) Construction in Progress (2011 - 2016) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Construction in Progress for 3 consecutive years, with $12000.0 the latest figure, recorded in Q4 2016.
- In Q4 2016, Construction in Progress changed N/A year-over-year to $12000.0; the TTM figure through Dec 2016 stood at $12000.0 (changed N/A YoY), while the FY2016 annual figure was $12000.0, changed N/A from the prior year.
- Construction in Progress retreated to $12000.0 in Q4 2016 per AMRN's latest filing, from $72000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $72000.0 in Q4 2012 and bottomed at $12000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | - |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2012 | 72,000.00 |
| Dec 31, 2011 | 288,000.00 |